Congenital Hearing Loss

May 31, 2021 New option is convenient and provides significant savings, leaders say. By: AdventHealth, and Adventist Review D ispatchHealth, a provider of in-home medical care in the United States, recently announced a partnership with AdventHealth, one of the largest faith-based health systems in the U.S., to offer patients an expanded opportunity to receive care in the comfort of their own home. The new service will help provide greater access, convenience, and support for consumers and will initially be offered in several cities in Florida as well as the Kansas City metro area. DispatchHealth has built a complete platform for delivering, coordinating, and providing medical care to patients in their homes. AdventHealth patients and providers in the Florida cities of Daytona Beach, Ocala, and Orlando, as well as in Kansas City, will now be able to request DispatchHealth's acute medical care for a wide range of common to complex injuries and illnesses, including viral infe

In-home care providers ConcertoHealth and Perfect Health merged under the "ConcertoCare" name in February. Since then, ConcertoCare leaders have been preparing for what's likely to be an action-packed 2021. The New York-based organization's plans include an expansion into the Program of All-Inclusive Care for the Elderly (PACE) space, plus an entry into the world of direct contracting. As for the former, ConcertoCare will officially launch its first PACE operation later this year in Virginia, Chairman and CEO Dr. Julian Harris told Home Health Care News. Advertisement "In that model, we support adults over 55 who meet nursing home-eligibility standards," Harris said. "We provide them with a combination of an intensive home-based care model, as well as support through the context of a PACE center." The PACE concept has been around for years, but it has gained even more traction as of late due to the current focus on home- and commu

By Carole Estabrooks and Yuting Song Most Canadians are familiar with nursing homes or long-term care facilities that provide 24-hour care to seniors who are no longer able to care for themselves independently — but we don't spend a lot of time thinking about them. Given our rapidly aging population, and the likelihood that someone we love, or maybe even ourselves, will be living there one day, maybe we should. What might surprise many is that 80 per cent of residents in Canadian nursing homes are now living with some level of cognitive impairment. This number is expected to rise. By 2037, there will be an estimated 920,000 Canadians living with dementia. What does this mean for our nursing homes? Care needs are increasingly complex and demanding — and nursing homes are already struggling to provide the level of care required for even basic needs. The future looks bleak, unless we change our approach. We recently published a study documenting the frequency with

Barry Schnur, CEO of David Schnur Associates, hosted a lively technical discussion on new materials and processes for interventional delivery systems at MD&M BIOMEDigital. Panelists in "DSA Critical Insights: Advanced Catheter Manufacturing," included Jochen Ulmer, vice president of medical products at Euroflex and G. Rau GmbH; Robert Foley, president of Cobalt Polymers; Darren Vine, business development and marketing director at XL Precision; and Ryan Balco, business unit director, engineered shafts at Nordson Medical. Schnur started off this session with a discussion with Ulmer about nitinol and what makes this material a more-compelling option for catheter manufacturers. Schnur asked Ulmer to explain what is meant by catheter-quality nitinol tubing, and Ulmer said that there are two ways that manufacturers look at nitinol tubing, based on their needs. "One is mainly driven by OD and ID wall tolerances," he said. "That's from the perspective of

New York, May 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Urinary Catheter Market Research Report by Product, by Type, by Application, by Usage, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06063295/?utm_source=GNW Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available. The United States Urinary Catheter Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative

Introduction A peripherally inserted central catheter (PICC) is essential in the treatment and nursing of patients requiring intensive care, or for patients suffering from cancer. A PICC is especially important for the chemotherapy and nutritional support of cancer patients. The infusion of chemotherapy drugs through a PICC not only reduces the risk of drug extravasation and the stimulation of peripheral blood vessels, it also satisfies the demand of having a catheter during the interval of chemotherapy in the outpatient setting. However, studies have shown that the incidence of venous thromboembolism (VTE) of the upper extremity in patients with PICC is significantly higher than that in patients with a central venous catheter. 1 Especially for patients with cancer (whose blood is in hypercoagulable state or vascular endothelium is injured by long-term chemotherapy), the incidence of PICC-related VTE has increased significantly to 5.6–12%, 2,3 and has become an important cause

BOERNE, Texas , May 24, 2021 /PRNewswire/ -- Prytime Medical Devices, Inc. announced today it has received both UK and CE Mark Approval for its next-generation ER-REBOA PLUS™ Catheter. Designed for improved ease of use, this catheter replaces the market defining ER-REBOA™ catheter and represents an important evolution of REBOA technology. The new catheter is REBOA Refined for controlling non-compressible truncal hemorrhage. "With this milestone, the new and improved ER-REBOA PLUS™ Catheter will now be available for patients in the UK and Europe in addition to our previous approvals in the US and Canada ," said Andrew Holman , CCO at Prytime Medical. "REBOA interest in the global trauma community continues to grow, so we work hard to continue to bring industry best solutions to physicians world-wide. We are pleased the next-generation ER-REBOA PLUS™ Catheter is available to our expanding global community of users." The ER-REBOA PLUS™ Catheter maintains all the

The following is a press release from the Oregon Academy of Family Physicians. KLAMATH FALLS, Ore. – Stewart L. Decker, MD, FAAFP, FWMS, assumed his role as President of the Oregon Academy of Family Physicians (OAFP) at the Academy's annual business meeting on April 24, which was held virtually. Dr. Decker has been a member of the OAFP since 2014. His term as President will last one year. Dr. Decker received his medical degree at University of Minnesota Medical School in 2014 and completed his residency in 2017 at OHSU Cascades East Family Medicine Residency Program. While a medical student, Dr. Decker was a member of the Minnesota Academy of Family Physicians and was active in the American Academy of Family Physicians (AAFP) as well. Before graduating, he spent a year in Peru, where he earned a certificate in international public health. As a resident, Dr. Decker held many national positions, including Resident Delegate to the Congress

She started her physician career later than most—with four children, a husband and dog at home—just out of medical school at 43 and in her first physician employment at 46 in a closed model health maintenance organization. On her first day, more than 30 patients were waiting to see her, a veritable conveyer belt. That wasn't what Barbara Hummel, MD, had in mind when she pursued a career as a family physician. She imagined a family practice where she could get to know her patients and spend some time moving them in heathy directions. "It was herd them in, herd them out. Half the time, I wasn't seeing my own patients," she recalled. "I was doing urgent care for doctors who were doing urgent care for other doctors. I left there feeling that wasn't what I went back to school for." After a short stint with a small, multispecialty practice and a year working in urgent care, she made the big decision—she began preparing her own practice. Renting space

Financial assistance and sliding fee discounts are available to eligible patients, as stated on the front door of the CHC/SEK Clinic in Fort Scott. Community Health Center of Southeast Kansas, Fort Scott, is still in the planning stage of the new site they purchased, the old Price Chopper store at 2322 S. Main. "Planning on the renovation of Price Chopper is going smoothly," Krista Postai, CEO and president, said. "It will have walk-in care along with regular medical clinic space and diagnostic, including x-ray, CT-scanner and bone density diagnostic equipment, offices for behavioral health/addiction treatment staff and other support staff and a drive-through pharmacy." Krista Postai. Submitted photo. "No start date for renovation, as of yet," Postai said. "To help offset the expense of renovation, CHC/SEK was the recipient of a $1.1 million federal grant through the American Rescue Plan," she said. "A large portion of the diagnost

Every weekend during Asian-American and Pacific Islander Heritage Month, we'll be lifting up the voices of our local AAPI community. Tonight, we begin with Dr. Benjamin Ha, who is a successful family physician in our community. and you're going to want to 'stay tuned' to hear about his fun hobby. According to Kaiser Permanente Family Physician Dr. Benjamin Ha's wife, Nina said you can really tell when a doctor is a good doctor, when they truly listen to you. It's something she noticed about her husband when they first started dating, and something she hears about him from people all the time. "I may be a little biased, but I just feel so incredibly blessed that God has given me a husband who truly has a heart to help others," Mrs. Ha said. "I just think for me and the kids, he's a real life superhero." Dr. ha, has been family physician at Kaiser Permanente in Bakersfield, since 2003. He's even been recognized as Kern County&

Headwinds ranging from an expected renewal of political wrangling over the price of prescription drugs to increasing pressure on sales of established treatments have largely, but not entirely, kept pharmaceutical companies from enjoying the increases of their biotech counterparts, as reflected in the share prices of exchange-traded funds (ETFs) consisting of pharma equities. Two of three pharma ETFs showed year-over-year declines as of November 13, while the third showed an increase in the low single digits. That ETF was the NYSE ARCA Pharmaceutical Index (DRG), which rose 2.8% year-over-year, to $608.31. By comparison, SPDR S&P Pharmaceuticals ETF (XPH) fell 12.7%, to $38.14, while iShares U.S. Pharmaceuticals ETF (IHE) dipped by 6.5% from a year ago, to $143.91. Below is a list of this year's top 10 pharmaceutical companies, ranked by market cap as of November 13, 2019, as furnished by the companies on their websites; by the exchanges on which they trade their shares;

Visiongain has published a new report on Global Pharmaceutical Product Information Management System Market Report Forecast 2020-2030. Forecasts by Offering (Solutions and Services), by Deployment Models (On-Premise and Cloud Based), and by Organization Size (Small and Medium Enterprises and Large Enterprises). PLUS, Profiles of Leading Pharmaceutical Product Information Management SystemCompanies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios Visiongain's analyst says: 'Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector'. Download Exclusive Sample of Report @   https://www.visiongain.com/report/product-information-management-system-market-2020/#download_sampe_div COVID-19 Impact on Global Pharmaceutical Product Information Management System Market COVID-19 outbreak resulted in a sudden in

The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the fight against COVID-19. From Johnson & Johnson to Shanghai Pharmaceuticals, Pharmaceutical Technology lists the top ten pharmaceutical companies in 2020, based on revenues. The world's biggest pharmaceutical companies: Top ten by revenue 1. Johnson & Johnson – $56.1bn 2. Pfizer – $51.75bn 3. Roche – $49.23bn 4. Novartis – $47.45bn 5. Merck & Co. – $46.84bn 6. GlaxoSmithKline – $44.27bn Global Data Pharma Decode the future to profit from faster, more informed decisions Powered by GlobalData's proprietary intelligence, our free Pharma Data Packs provide essential insights across a variety of key themes disrupting the market that keep CEOs awake at night. Find out more 7. Sanofi – $40.46bn 8. AbbVie – $33.26bn 9. Takeda – $30.52bn 10. Shanghai Pharmaceuticals Holding – $26.69bn 1. Johns